Search Results 41-50 of 15313 for ETU
Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...
The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary ...
Freund BE, Shourav MMI, Feyissa AM, Meschia JF, Yonas A, Barrett KM, Tatum WO, Lin MP. Seizures in Cerebral Amyloid Angiopathy: A Systematic Review and ...
Mayo Clinic College of Medicine and Science students share their perspectives of the 2021 Education and Technology Forum.
This research is looking at two conditions, Essential Thrombocythemia (ET) and Polycythemia Vera (PV). ET causes people to produce too many blood cells called ...
MeTeOR participants will complete questionnaires and performance tests and undergo MRI and radiographs 12 years after randomization. Our analyses of cartilage ...
Young girl with rare disease gets life-changing diagnosis and targeted therapy at Mayo Clinic. Susan Murphy. February 28, 2022.
To combat heart disease and cancer, genomics researcher looks abroad. Genetic technology has the potential to significantly improve human health by ...
The purpose of this study is to evaluate Endologix AFX endovascular abdominal aortic aneurism system with anatomical fixation against other approved ...
Mayo Clinic Researchers Find New Molecule to Target in Pancreatic Cancer Treatment. mayonewsreleases. January 2, 2013. Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.